share_log

Prestige Consumer Healthcare (NYSE:PBH) Hits New 1-Year Low at $49.81

Prestige Consumer Healthcare (NYSE:PBH) Hits New 1-Year Low at $49.81

威望消費者醫療保健(紐約證券交易所代碼：PBH)跌至49.81美元的一年新低
Financial News Live ·  2022/09/22 12:51

Prestige Consumer Healthcare Inc. (NYSE:PBH – Get Rating)'s share price hit a new 52-week low during trading on Thursday . The company traded as low as $49.81 and last traded at $49.81, with a volume of 18 shares. The stock had previously closed at $50.55.

威望消費者醫療保健公司(紐約證券交易所代碼：PBH-GET Rating)的股價在週四的交易中創下52周來的新低。該公司股價一度跌至49.81美元，最新報49.81美元，成交量為18股。此前該股收盤價為50.55美元。

Analysts Set New Price Targets

分析師設定新的價格目標

Separately, DA Davidson reaffirmed a "neutral" rating on shares of Prestige Consumer Healthcare in a report on Tuesday, August 9th. Two equities research analysts have rated the stock with a hold rating and three have issued a buy rating to the company's stock. According to MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and a consensus target price of $80.50.

另外，DA Davidson在8月9日(星期二)的一份報告中重申了對Prestige Consumer Healthcare股票的“中性”評級。兩名股票研究分析師對該股的評級為持有，三名分析師對該公司股票的評級為買入。根據MarketBeat.com的數據，該股目前的共識評級為“適度買入”，共識目標價為80.50美元。

Get
到達
Prestige Consumer Healthcare
威望消費者醫療保健
alerts:
警報：

Prestige Consumer Healthcare Price Performance

威望消費者醫療保健價格表現

The company has a current ratio of 2.09, a quick ratio of 1.23 and a debt-to-equity ratio of 0.93. The firm has a market cap of $2.50 billion, a PE ratio of 12.67, a price-to-earnings-growth ratio of 1.51 and a beta of 0.55. The stock has a 50 day simple moving average of $55.44 and a 200-day simple moving average of $55.50.

該公司的流動比率為2.09，速動比率為1.23，債務權益比率為0.93。該公司市值為25億美元，市盈率為12.67倍，市盈率為1.51倍，貝塔係數為0.55。該股的50日簡單移動均線切入位為55.44美元，200日簡單移動均線切入位為55.50美元。

Institutional Investors Weigh In On Prestige Consumer Healthcare

機構投資者看好Prestige Consumer Healthcare

A number of institutional investors have recently bought and sold shares of the business. BlackRock Inc. increased its stake in Prestige Consumer Healthcare by 12.4% in the 1st quarter. BlackRock Inc. now owns 9,115,718 shares of the company's stock worth $482,584,000 after buying an additional 1,004,337 shares in the last quarter. Vanguard Group Inc. increased its stake in Prestige Consumer Healthcare by 1.1% in the 1st quarter. Vanguard Group Inc. now owns 5,559,553 shares of the company's stock worth $294,322,000 after buying an additional 59,740 shares in the last quarter. Dimensional Fund Advisors LP grew its position in shares of Prestige Consumer Healthcare by 0.4% during the first quarter. Dimensional Fund Advisors LP now owns 3,448,246 shares of the company's stock valued at $182,552,000 after purchasing an additional 12,790 shares in the last quarter. State Street Corp grew its position in shares of Prestige Consumer Healthcare by 4.9% during the second quarter. State Street Corp now owns 1,921,456 shares of the company's stock valued at $112,982,000 after purchasing an additional 89,131 shares in the last quarter. Finally, Macquarie Group Ltd. grew its position in shares of Prestige Consumer Healthcare by 4.4% during the second quarter. Macquarie Group Ltd. now owns 1,887,479 shares of the company's stock valued at $110,984,000 after purchasing an additional 79,519 shares in the last quarter. Hedge funds and other institutional investors own 99.37% of the company's stock.
一些機構投資者最近買賣了該公司的股票。貝萊德股份有限公司在第一季度增持了Prestige Consumer Healthcare 12.4%的股份。貝萊德股份有限公司現在持有該公司9,115,718股股票，價值482,584,000美元，該公司在上個季度又購買了1,004,337股。先鋒集團第一季度增持Prestige Consumer Healthcare股份1.1%。先鋒集團目前持有該公司5,559,553股股票，價值294,322,000美元，上一季度又購買了59,740股。Dimension Fund Advisors LP在第一季度將其在Prestige Consumer Healthcare的股票頭寸增加了0.4%。Dimension Fund Advisors LP現在擁有該公司3,448,246股股票，價值182,552,000美元，上個季度又購買了12,790股。道富集團在第二季度持有的Prestige Consumer Healthcare股票增加了4.9%。道富銀行目前持有1,921,456股該公司股票，價值112,982,000美元，上一季度又購買了89,131股。最後，麥格理集團第二季度增持Prestige Consumer Healthcare股票4.4%。麥格理集團目前持有該公司1,887,479股股票，價值110,984,000美元，上一季度又購買了79,519股。對衝基金和其他機構投資者持有該公司99.37%的股票。

About Prestige Consumer Healthcare

關於Prestige Consumer Healthcare

(Get Rating)

(獲取評級)

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.

威望消費者保健公司及其子公司在美國和國際上開發、製造、營銷、分銷和銷售非處方藥(OTC)健康和個人護理產品。該公司在北美OTC Healthcare和國際OTC Healthcare兩個部門運營。

Featured Stories

專題報道

  • Get a free copy of the StockNews.com research report on Prestige Consumer Healthcare (PBH)
  • The Institutions Hold On To Darden Restaurants International
  • What Steelcase's Earnings Say About the Return to the Office?
  • Is The Golden Age Of Homebuilding Already Over?
  • These 3 Big Dividend Payers Also Boast Strong Price Growth
  • Natural Gas Prices Continue To Rally, These Stocks Should Benefit
  • 免費獲取StockNews.com關於Prestige Consumer Healthcare(PBH)的研究報告
  • 這些機構持有達頓餐飲國際公司的股份
  • 斯蒂爾凱斯的收益説明瞭他重返辦公室的原因嗎？
  • 住房建設的黃金時代已經結束了嗎？
  • 這三大股利支付者也擁有強勁的價格增長
  • 天然氣價格繼續回升，這些股票應該會受益

Receive News & Ratings for Prestige Consumer Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Prestige Consumer Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.

獲得《尊貴消費者保健日報》的新聞和評級-在下面輸入您的電子郵件地址，通過MarketBeat.com的免費每日電子郵件時事通訊接收對Prestige Consumer Healthcare和相關公司的最新新聞和分析師評級的每日簡要摘要。

声明：本內容僅用作提供資訊及教育之目的，不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論